Row triangle Shape Decorative svg added to bottom

Awards & Partnerships

These relationships and recognitions reflect where our work intersects with real-world program complexity, executive decision-making, and industry-wide impact.

Virtue 340B’s work is grounded in independent oversight, but validated through partnerships, recognition, and engagement across the healthcare and pharmacy ecosystem.

Row triangle Shape Decorative svg added to top

Program Management Partnership

Virtue 340B partners with GCA 340B to provide independent audit and risk oversight within vendor-managed 340B environments.

GCA 340B delivers operational program management across complex 340B programs, while Virtue 340B provides an independent layer of review designed to identify hidden exposure, validate program integrity, and strengthen audit readiness.

This structure allows organizations to benefit from both operational execution and independent oversight—without conflict.

As reflected in GCA 340B’s partnership narrative, this model enables healthcare organizations to proactively prepare for HRSA-level audit scrutiny, strengthening both compliance readiness and leadership confidence.

HANYS Marketplace — Healthcare Association Partnership

Virtue 340B is a selected partner of HANYS Marketplace®, connecting New York hospitals and health systems with independent 340B oversight and advisory support.

HANYS Marketplace curates vetted solutions for healthcare providers, ensuring access to trusted partners aligned with operational and governance priorities.

Through this partnership, Virtue 340B provides:

  • Independent 340B compliance oversight
  • Risk-based audit and monitoring
  • Executive-level clarity for complex programs

“Virtue 340B provides independent, high-integrity oversight that helps New York’s hospitals and health systems strengthen governance and protect the durability of their 340B programs.”

-HANYS Marketplace®

Independent oversight is most valuable where operational complexity is highest.

Discover how an independent 340B audit can uncover hidden savings while protecting your eligibility from HRSA penalties.

Healthcare Business Review — 2025 & 2026 Recognition 

These recognitions are based on industry nominations and evaluation by executive leadership and editorial review panels.

The 2026 feature highlights a core principle of Virtue’s work:

  • Programs often operate with limited internal visibility
  • Risk can accumulate quietly beneath reported savings
  • Leadership requires clear, defensible oversight

Virtue 340B was recognized by Healthcare Business Review as:

  • Top 340B Consulting Services — 2026
  • Top Healthcare Consulting & Audit Services — 2025
Row triangle Shape Decorative svg added to top

RXinsider Pharmacy500 & Industry Platform Presence

Virtue 340B has been recognized as a Pharmacy500 company by RXinsider, reflecting measurable impact on pharmacy operations and the broader supply chain ecosystem.

The Pharmacy500 recognizes organizations that have significantly influenced dispensing pharmacy performance across the United States.

RXinsider itself serves as a pharmacy-focused market intelligence and communications platform, providing resources, publications, and insights to pharmacy leadership and operational stakeholders.

Through this platform, Virtue maintains visibility within the pharmacy ecosystem—engaging decision-makers and contributing to industry-wide understanding of 340B risk and oversight.

New York State Certified Minority Business Enterprise (MBE)

Virtue 340B is a certified Minority Business Enterprise (MBE) through New York State’s Division of Minority and Women’s Business Development.

  • Certification awarded: July 18, 2024

This certification confirms verified ownership, control, and operational independence—reinforcing Virtue’s structure as an independent advisory firm without vendor conflicts or external influence.

Optimize Your 340B Program Through Expert Training

Virtue 340B is trusted where 340B complexity is highest, providing independent oversight that leadership can rely on, validate, and defend.